Leveraging people, processes and technology to deliver for biotech
Small and emerging biotech companies have varied challenges compared to mid-large size pharma companies, with paths that aren’t always as straightforward as taking a compound through clinical development to launch. Our biotech clients drive towards these key inflection points from proof of concept to compound development, to capital raises based on data, to acquisition, and sometimes even launching a compound themselves. And they need a partner that brings deep clinical, scientific, therapeutic, and regulatory expertise, and still being agile and nimble to help them develop and execute their plans with confidence.
In this podcast, Jennifer Warneke, Senior Vice President of Parexel Biotech. Sarah Berry, Senior Director, Portfolio Management, Parexel Biotech and Daniel Montoya Giraldo, Project Director, Parexel Biotech discuss the different goals that they help our biotech customers achieve, what a good partnership looks like and examples of how they address challenges when they arise.
Related Insights
Podcast
De-risking Drug Development | Episode 5: Expand the use and value of your product over time
Sep 25, 2024
Video
Overcoming asset transfer challenges during a merger and acquisition (M&A)
Oct 20, 2021
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Article
Three strategies for articulating a coherent product value story
Dec 18, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Case Study
Case Study Marketing Authorization Transfer
Nov 25, 2021
Case Study
Case Study Lifecycle maintenance
Nov 25, 2021
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Podcast
Pharma Talk Radio: Building a Successful Relationship with your Development Partner
Oct 5, 2021
Related Insights
Podcast
De-risking Drug Development | Episode 5: Expand the use and value of your product over time
Sep 25, 2024
Video
Overcoming asset transfer challenges during a merger and acquisition (M&A)
Oct 20, 2021
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Article
Three strategies for articulating a coherent product value story
Dec 18, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Case Study
Case Study Marketing Authorization Transfer
Nov 25, 2021
Case Study
Case Study Lifecycle maintenance
Nov 25, 2021
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Podcast
Pharma Talk Radio: Building a Successful Relationship with your Development Partner
Oct 5, 2021